Amdocs Limited Submits Fiscal Year 2025 Annual Report

Amdocs has filed its Fiscal 2025 Annual Report (Form 20-F), detailing continued growth and strategic advancements. The report highlights significant contract wins in BSS, OSS, managed services, and generative AI, alongside robust capital allocation including a $2.1 billion share repurchase authorization. Amdocs reported $4.53 billion in revenue, underscoring its commitment to digital transformation and innovation in the communications and media sectors.

Amdocs Files Fiscal 2025 Annual Report, Highlighting Continued Growth and Strategic Initiatives

**JERSEY CITY, NJ** – Amdocs (NASDAQ: DOX), a global leader in software and services for the communications and media industries, has officially submitted its Annual Report on Form 20-F for the fiscal year concluding September 30, 2025. The filing, made with the U.S. Securities and Exchange Commission on December 15, 2025, provides a comprehensive overview of the company’s financial performance and operational achievements over the past year.

The report, accessible on Amdocs’ investor relations website, offers shareholders and interested parties detailed financial statements and critical insights into the company’s business trajectory. Amdocs has reiterated its commitment to transparency by offering to provide a complimentary copy of the 2025 annual report to any shareholder upon request.

This regulatory milestone arrives at a dynamic period for Amdocs, marked by significant contract wins and strategic partnerships. Recent announcements highlight the company’s expanding role in driving digital transformation for major telecommunications players. Notably, a multi-year Business Support Systems (BSS) agreement with Telia Finland and an Operations Support Systems (OSS) modernization deal with Vivo underscore Amdocs’ capability in transforming core network and customer management platforms. Furthermore, an extended managed services agreement with Globe, now encompassing the network domain, signals continued trust and reliance on Amdocs’ expertise.

These operational developments are complemented by Amdocs’ robust capital allocation strategy. The company has authorized substantial share repurchase programs, totaling $2.1 billion, with a significant portion, $1.12 billion, remaining available. This reflects management’s confidence in the company’s valuation and its commitment to enhancing shareholder value.

While recent contract wins have been generally positive, the market has shown a tendency for short-term price volatility following these announcements, a pattern observed in the company’s historical trading activity. For instance, despite positive news surrounding major agreements on November 11, 2025, the stock experienced a modest decline. Conversely, a recent AI platform win with e& UAE on December 9, 2025, resulted in a slight uptick. Investors will likely scrutinize the Form 20-F for deeper analysis of how these new contracts are impacting the company’s top and bottom lines, and how the substantial share repurchase authorizations are being strategically utilized.

The filing also provides context on Amdocs’ financial positioning, including details on its investment portfolio, such as short-term interest-bearing investments and available-for-sale securities, as well as its liabilities, like those related to defined benefit plans.

Amdocs continues to position itself at the forefront of technological innovation, particularly in the realm of artificial intelligence. The company’s amAIz GenAI platform is a testament to its focus on enabling service providers to leverage AI for driving digital modernization, automating intelligent networks, and unlocking new revenue streams. With reported revenue of $4.53 billion in fiscal 2025, Amdocs demonstrates a strong market presence and a forward-looking strategy aimed at transforming the communications and media landscape.

**Key Financial and Operational Highlights from the Filing:**

* **Fiscal Year End:** September 30, 2025
* **Form Filed:** Annual Report on Form 20-F
* **Filing Date:** December 15, 2025
* **Key Financial Instruments Mentioned:** Short-term interest-bearing investments, available-for-sale securities, defined benefit plan obligations.
* **Capital Allocation:** $2.1 billion in share repurchase authorizations, with $1.12 billion remaining.
* **Recent Operational Wins:** Multi-year BSS and OSS agreements, expanded managed services, and generative AI platform deployments.

The Form 20-F serves as a crucial document for understanding Amdocs’ financial health, strategic execution, and its ongoing commitment to innovation within the rapidly evolving technology sector.

***

**About Amdocs:**

Amdocs empowers the world’s leading communications and media companies to accelerate innovation and deliver exceptional customer experiences at scale. Our comprehensive portfolio of software products and services enables service providers to harness the transformative power of artificial intelligence, driving digital modernization, cloud adoption, intelligent network automation, and new revenue opportunities. With our talented people across the globe, we partner with our customers to turn advanced technology into measurable business outcomes, enriching lives and advancing a more connected society. Listed on the NASDAQ Global Select Market, Amdocs reported revenue of $4.53 billion in fiscal 2025.

Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/14563.html

Like (0)
Previous 18 hours ago
Next 18 hours ago

Related News